Increasing concerns about the rising rates of antibiotic therapy failure and advances in
single-cell analyses have inspired a surge of research into antibiotic persistence. Bacterial …

Clinically significant antibiotic resistance has evolved against virtually every antibiotic
deployed. Yet the development of new classes of antibiotics has lagged far behind our growing …

Rapid, inexpensive, and sensitive nucleic acid detection may aid point-of-care pathogen
detection, genotyping, and disease monitoring. The RNA-guided, RNA-targeting clustered …

The great majority of globally circulating pathogens go undetected, undermining patient care
and hindering outbreak preparedness and response. To enable routine surveillance and …

Encounters between immune cells and invading bacteria ultimately determine the course of
infection. These interactions are usually measured in populations of cells, masking cell-to-…

Increasing antibiotic resistance requires the development of new approaches to combating
infection. Virulence gene expression in vivo represents a target for antibiotic discovery that …

The coronavirus disease 2019 (COVID-19) pandemic has demonstrated a clear need for
high-throughput, multiplexed and sensitive assays for detecting severe acute respiratory …

Certain bacterial pathogens are able to evade the host immune system and persist within
the human host. The consequences of persistent bacterial infections potentially include …

The two subunits of the human class I histocompatibility antigen (HLA)-A2 have been expressed
at high levels (20-30 mg/liter) as insoluble aggregates in bacterial cells. The aggregates …

Despite the urgent need for new antitubercular drugs, few are on the horizon. To combat the
problem of emerging drug resistance, structurally unique chemical entities that inhibit new …